A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04

NCT01989663 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: 1% vaginally applied tenofovir gel
DRUG: Tenofovir film- 10mg
DRUG: Tenofovir Film-40 mg
OTHER: HEC Placebo Gel
OTHER: Placebo Vaginal Film

Sponsor

CONRAD

Collaborators

[object Object]
[object Object]